A dynamic population model of disease progression in COPD.
about
Systematic review of the evidence relating FEV1 decline to giving up smokingNew clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analysesWhat determines subjective health status in patients with chronic obstructive pulmonary disease: importance of symptoms in subjective health status of COPD patientsApplication of a theoretical model to evaluate COPD disease managementImproving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis.Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary disease.Forecasts of COPD mortality in Australia: 2006-2025.Association between lung function and exacerbation frequency in patients with COPD.Future impact of various interventions on the burden of COPD in Canada: a dynamic population modelPatient-centered appointment scheduling using agent-based simulationPresent and future costs of COPD in Iceland and Norway: results from the BOLD studyImproving clinical reality in chronic obstructive pulmonary disease economic modelling : development and validation of a micro-simulation approach.Moving beyond a limited follow-up in cost-effectiveness analyses of behavioral interventions.Effects of dexmedetomidine on oxygenation and lung mechanics in patients with moderate chronic obstructive pulmonary disease undergoing lung cancer surgery: A randomised double-blinded trialAdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model UsersModeling corticosteroid effects in a rat model of rheumatoid arthritis I: mechanistic disease progression model for the time course of collagen-induced arthritis in Lewis rats.Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up StudyProjecting the COPD population and costs in England and Scotland: 2011 to 2030.Obstructive lung disease models: what is valid?Tiotropium therapy and mortality risk in COPD patients: the most severe, the most protected? Evaluation of Celli B, Decramer M, Kesten S, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary diseEvaluation of self-management interventions for chronic obstructive pulmonary disease.A systematic review of quality and cost-effectiveness derived from Markov models evaluating smoking cessation interventions in patients with chronic obstructive pulmonary disease.Models for estimating projections for disease prevalence and burden: a systematic review focusing on chronic obstructive pulmonary disease.Mathematical Modeling in Tobacco Control Research: Initial Results From a Systematic Review.Effects of whole body vibration on pulmonary function, functional exercise capacity and quality of life in people with chronic obstructive pulmonary disease: a systematic review.Network vs. pairwise meta-analyses: a case study of the impact of an evidence-synthesis paradigm on value of information outcomes.The burden of smoking-related diseases in Brazil: mortality, morbidity and costs.The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.A lifetime Markov model for the economic evaluation of chronic obstructive pulmonary disease.Frequency of multi-dimensional COPD indices and relation with disease activity markers.Comparison of health-related quality of life between patients with chronic obstructive pulmonary disease and the general population.A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.Early detection of COPD in general practice: patient or practice managed? A randomised controlled trial of two strategies in different socioeconomic environments.An attempt at modeling COPD epidemiological trends in France.Uncertainty Analysis in Population-Based Disease Microsimulation Models
P2860
Q28385603-3E1D4FD9-9B19-48CB-A28A-FFE246A6E6FCQ30419928-F11CF578-9A3D-49E2-B672-330833D4955AQ30485969-A96F8194-6E81-4835-9F8F-5A8AECF1F2BAQ33546690-56FED072-23C2-4A84-848B-4A035347EC91Q33794408-B37669F8-957C-4508-81CE-E3FE6C731597Q34031553-9BB1424B-6F33-4BF8-A955-8F5BD07A411CQ34165521-C949E3F5-76C6-4667-94F7-8658238BEADAQ34432556-850FF075-E151-4DA2-B98C-9C291A4AB97AQ34447408-DE6B34BF-5445-48A4-A944-CA25A2042069Q35570239-FCEC5FFC-D10A-4FF7-B39A-76298B2B258DQ35906562-8D6E0BEA-CF02-4C5F-BA27-507A21519068Q36579746-5851A3BD-130A-49A8-9BDE-E068E793B901Q36629956-3EBE2BD1-4525-4703-95C5-E8DE45D98638Q36658522-0262551A-AF7F-41B8-9F93-B7C44E840522Q36698876-15C2D3EB-187E-45D1-BAFF-5194F0472D7CQ36952913-007B09FF-FA59-47F0-8518-CF7AEA77005EQ37168335-CDB7B985-0EFF-4EDD-B674-5B4E28FEF7CDQ37224917-42167498-0E91-44EF-A193-745656550D37Q37437429-2EC08E65-2B4F-4370-A441-118B9921726EQ37743513-D9E7FB87-A403-43E9-8F96-42837D1601E7Q38042486-1087C463-DE92-432F-B13B-575BE7CE820BQ38323792-80237E7A-B245-4C80-964F-D6F0C3EAF903Q38402341-ED9A07F5-3B9A-49A4-BA44-B39840FFF163Q38482308-DDF7138C-2C53-4A1B-805E-1EE71F00F3E3Q38514299-20275A1F-5CC8-4F42-868A-0D807B5EA586Q39177092-0A404696-B647-4D26-899E-11C145B1C73EQ40709069-B7231BC1-14F3-4237-AF56-948E385D9E9FQ44047476-142C50BA-F83C-4A88-BB71-BD9519F8F213Q47380594-DD175579-3E48-468C-9613-D74C58774604Q48270757-4EB7FA77-3AB8-4B67-A884-4FEE8D01D93EQ48361900-05D23CD0-0F57-4320-B9F8-B157633EA277Q51103821-1BC4509E-CCFA-4C4F-BA08-78045A4F1F72Q51789665-B56A1C68-7008-49B5-86DC-54262EA6BAC5Q55514034-EAD91118-702E-494F-AF74-399BA0489D35Q58701365-B3533CFE-6F9E-472B-8385-FDF529555F08
P2860
A dynamic population model of disease progression in COPD.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A dynamic population model of disease progression in COPD.
@en
type
label
A dynamic population model of disease progression in COPD.
@en
prefLabel
A dynamic population model of disease progression in COPD.
@en
P2093
P1476
A dynamic population model of disease progression in COPD
@en
P2093
E F M Wouters
M Hoogendoorn
M L L van Genugten
R T Hoogenveen
P304
P356
10.1183/09031936.05.00122004
P577
2005-08-01T00:00:00Z